Lactoferrin decreases inflammatory response by cystic fibrosis bronchial cells invaded with Burkholderia cenocepacia iron-modulated biofilm

International Journal of Immunopathology and Pharmacology

Volumn 24, Issue 4, 2011, Pages 1057-1068

  Valenti, P ^a   Catizone, A ^a   Pantanella, F ^a   Frioni, A ^a   Natalizi, T ^a   Tendini, M ^a   Berlutti, Francesca ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Cystic fibrosis bronchial cell infection; Inflammatory response; Iron modulated biofilm; Lactoferrin

Indexed keywords

BOVINE LACTOFERRIN; INTERLEUKIN 11; INTERLEUKIN 1BETA; IRON; LACTOFERRIN; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 6; INTERLEUKIN 8;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BIOFILM; BRONCHUS; BURKHOLDERIA CENOCEPACIA; CELL STRUCTURE; CONTROLLED STUDY; CYSTIC FIBROSIS; GENE EXPRESSION; HOMEOSTASIS; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; BACTERIAL GROWTH; BURKHOLDERIA INFECTION; CELL INVASION; CELL NUCLEUS; CELLULAR DISTRIBUTION; CYTOKINE PRODUCTION; CYTOPLASM; EXTRACELLULAR MATRIX; HUMAN; IN VITRO STUDY; LUNG FIBROSIS; PROTEIN EXPRESSION;

EID: 84856559833     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201102400423     Document Type: Article

References (32)

1. O'Sullivan BP, Freedman SD. Cystic fibrosis. Lancet 2009; 373:1891-904.
2. Reid DW, Withers NJ, Francis L, Wilson JW, Kotsimbos TC. Iron deficiency in cystic fibrosis: relationship to lung disease severity and chronic Pseudomonas aeruginosa infection. Chest 2002; 121:48-54. (Pubitemid 34114227)
3. Reid DW, Carroll V, O'May C, Champion A, Kirov SM. Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis. Eur Respir J 2007; 30:286-92. (Pubitemid 47194181)
4. Fischer R, Simmerlein R, Huber RM, Schiffl H, Lang SM. Lung disease severity, chronic inflammation, iron deficiency, and erythropoietin response in adults with cystic fibrosis. Pediatr Pulmonol 2007; 42:1193-97. (Pubitemid 350231871)
5. Ulrich M, Worlitzsch D, Viglio S, et al. Alveolar inflammation in cystic fibrosis. J Cyst Fibros 2010; 9:217-27.
6. O'Sullivan BP, Flume P. The clinical approach to lung disease in patients with cystic fibrosis. Semin Respir Crit Care Med 2009; 30:505-13.
7. Berlutti F, Morea C, Battistoni A, Sarli S, Cipriani P, Superti F, Ammendolia MG, Valenti P. Iron availability influences aggregation, biofilm, adhesion and invasion of Pseudomonas aeruginosa and Burkholderia cenocepacia. Int J Immun Pharmacol 2005; 18:661-70.
8. Moreau-Marquis S, Bomberger JM, Anderson GG, Swiatecka-Urban A, Ye S, O'Toole GA, Stanton BA. The DeltaF508-CFTR mutation results in increased biofilm formation by Pseudomonas aeruginosa by increasing iron availability. Am J Physiol Lung Cell Mol Physiol 2008; 295:25-37.
9. Valenti P, Antonini G. Lactoferrin: an important host defence against microbial and viral attack. Cell Mol Life Sci 2005; 62:2576-87. (Pubitemid 41721231)
10. Drevinek P, Mahenthiralingam E. Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence. Clin Microbiol Infect 2010; 16:821-30.
11. McClean S, Callaghan M. Burkholderia cepacia complex: epithelial cell-pathogen confrontations and potential for therapeutic intervention. J Med Microbiol 2009; 58:1-12.
12. Murray S, Charbeneau J, Marshall BC, LiPuma JJ. Impact of Burkholderia infection on lung transplantation in cystic fibrosis. Am J Respir Crit Care Med 2008; 178:363-71.
13. Sagel SD, Sontag MK, Accurso FJ. Relationship between antimicrobial proteins and airway inflammation and infection in cystic fibrosis. Pediatr Pulmonol 2009; 44:402-09.
14. Berlutti F, Superti F, Nicoletti M, Morea C, Frioni A, Ammendolia MG, Battistoni A, Valenti P. Bovine lactoferrin inhibits the efficiency of invasion of respiratory A549 cells of different iron-regulated morphological forms of Pseudomonas aeruginosa and Burkholderia cenocepacia. Int J Immunopathol Pharmacol 2008; 21:51-59. (Pubitemid 351501001)
15. Berlutti F, Schippa S, Morea C, Sarli S, Perfetto B, Donnarumma G, Valenti P. Lactoferrin downregulates pro-inflammatory cytokines upexpressed in intestinal epithelial cells infected with invasive or non invasive Escherichia coli strains. Biochem Cell Biol 2006; 84:351-57. (Pubitemid 44341310)
16. Legrand D, Elass E, Carpentier M, Mazurier J. Lactoferrin: a modulator of immune and inflammatory responses. Cell Mol Life Sci 2005; 62:2549-59. (Pubitemid 41722207)
17. Hayworth JL, Kasper KJ, Leon-Ponte M, et al. Attenuation of massive cytokine response to the staphylococcal enterotoxin B superantigen by the innate immunomodulatory protein lactoferrin. Clin Exp Immunol 2009; 157:60-70.
18. Petrucca A, Cipriani P, Valenti P, et al. Molecular characterization of Burkholderia cepacia isolates from cystic fibrosis (CF) patients in an Italian, CF center. Res Microbiol 2003; 154:491-98. (Pubitemid 37130251)
19. Cha C, Gao P, Chen YC, Shaw PD, Farrand SK. Production of acyl-homoserine lactone quorum-sensing signals by gram-negative plant-associated bacteria. Mol Plant Microbe Interact 1998; 11:1119-29. (Pubitemid 28486097)
20. Pantanella F, Berlutti F, Passariello C, Sarli S, Morea C, Schippa S. Violacein and biofilm production in Janthinobacterium lividum. J Appl Microbiol 2007; 102:992-99. (Pubitemid 46457480)
21. Siciliano R, Rega B, Marchetti M, Seganti L, Antonini G, Valenti P. Bovine lactoferrin peptidic fragments involved in inhibition of herpes simplex virus type 1 infection. Biochem Biophys Res Commun 1999; 264:19-23. (Pubitemid 29500456)
22. Eberl L. Quorum sensing in the genus Burkholderia. In J Med Microbiol 2006; 296:103-10. (Pubitemid 43375992)
23. Nichols D, Chmile J, Berger M. Chronic inflammation in the cystic fibrosis lung: alteration of inter- and intracellular signaling. Clinic Rev Allerg Immunol 2008; 34:146-62.
24. Sajjan U, Keshavjee S, Forstner J. Responses of well-differentiated airway epithelial cell cultures from healthy donors and patients with cystic fibrosis to Burkholderia cenocepacia infection. Infect Immun 2004; 72:4188-99. (Pubitemid 38821933)
25. Bergsbaken T, Fink SL, Cookson BT. Pyroptosis: host cell death and inflammation. Nat Rev Microbiol 2009; 7:99-109.
26. Kotrange S, Kopp B, Akhter A, et al. Burkholderia cenocepacia O polysaccharide chain contributes to caspase-1-dependent IL-1beta production in macrophages. J Leukoc Biol 2011; 89:481-88.
27. Douglas TA, Brennan S, Gard S, Berry L, Gangell C, Stick SM, Clements BS, Sly PD. Acquisition and eradication of P. aeruginosa in young children with cystic fibrosis. Eur Respir J 2009; 33:305-11.
28. Wongprompitak P, Sirisinha S, Chaiyaroj SC. Differential gene expression profiles of lung epithelial cells exposed to Burkholderia pseudomallei and Burkholderia thailandensis during the initial phase of infection. Asian Pac J Allergy Immunol 2009; 27:59-70.
29. Kuhara T, Yamauchi K, Iwatsuki K. Bovine lactoferrin induces interleukin-11 production in a hepatitis mouse model and human intestinal myofibroblasts. Eur J Nutr 2011; [Epub ahead of print]
30. Legrand D, Vigié K, Said EA, et al. Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells. Eur J Biochem 2004; 271:303-17. (Pubitemid 38130458)
31. Suzuki YA, Wong H, Ashida KY, Schryvers AB, Lönnerdal B. The N1 domain of human lactoferrin is required for internalization by caco-2 cells and targeting to the nucleus. Biochemistry 2008; 47:10915-20.
32. Paesano R, Berlutti F, Pietropaoli M, Goolsbee W, Pacifici E, Valenti P. Lactoferrin efficacy versus ferrous sulfate in curing iron disorders in pregnant and non-pregnant women. Int J Immunopathol Pharmacol 2010; 23:577-87.